Table 1 Characteristics of 2,061 patients with perforated and 7,232 patients with bleeding peptic ulcer in the counties of North Jutland, Aarhus and Viborg, Denmark.
Perforated peptic ulcer | Bleeding peptic ulcer | |||||
|---|---|---|---|---|---|---|
15–64 years N | 65–79 years N | 80+ years N | 15–64 years N | 65–79 years N | 80+ years N | |
Gender | ||||||
Female | 338 (42.0%) | 410 (55.2%) | 358 (69.8%) | 739 (35.5%) | 1329 (47.1%) | 1402 (59.1%) |
Male | 467 (58.0%) | 333 (44.8%) | 155 (30.2%) | 1347 (64.6%) | 1445 (52.1%) | 970 (40.9%) |
Ulcer-related drugs* | ||||||
Use† | 484 (60.1%) | 554 (74.6%) | 417 (81.3%) | 1434 (68.7%) | 2093 (75.4%) | 1950 (82.2%) |
No use | 321 (39.9%) | 189 (25.4%) | 96 (18.7%) | 652 (31.3%) | 681 (24.6%) | 422 (17.8%) |
Previous uncomplicated peptic ulcer disease | ||||||
No | 709 (88.1%) | 657 (88.4%) | 463 (90.3%) | 1829 (87.5%) | 2446 (88.2%) | 2115 (89.2%) |
Yes | 96 (11.9%) | 86 (11.6%) | 50 (9.7%) | 257 (12.6%) | 328 (11.8%) | 257 (10.8%) |
Comorbidity# | ||||||
Low | 616 (76.5%) | 378 (50.9%) | 273 (53.2%) | 1442 (68.2%) | 1322 (47.7%) | 1148 (48.4%) |
Moderate | 161 (20.0%) | 290 (39.0%) | 208 (40.6%) | 523 (25.1%) | 1139 (41.0%) | 1013 (42.7%) |
High | 28 (3.5%) | 75 (10.1%) | 32 (6.2%) | 141 (6.7%) | 313 (11.3%) | 212 (8.9%) |